A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk

International Journal of Cancer

Volumn 87, Issue 2, 2000, Pages 204-210

  Haiman, Christopher A ^a,b,d   Hankinson, Susan E ^a,c   Spiegelman, Donna ^a   De Vivo, Immaculata ^a,c   Colditz, Graham A ^a,b,c   Willett, Walter C ^a,b,c   Speizer, Frank E ^a,c   Hunter, David J ^a,b,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD CENTER FOR CANCER PREVENTION   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; ALLELE; ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE SEQUENCE; GENETIC RISK; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL;

ALLELES; AROMATASE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ESTRADIOL; ESTRONE; FEMALE; GENOTYPE; HUMANS; INTRONS; LINKAGE DISEQUILIBRIUM; MENOPAUSE; MICROSATELLITE REPEATS; MODELS, STATISTICAL; POLYMORPHISM, GENETIC; RISK; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC;

EID: 0034662307     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000715)87:2<204::AID-IJC8>3.0.CO;2-3     Document Type: Article

References (22)

1. BRODIE, A., Aromatase and its inhibitors: an overview. J. Steroid Biochem. Mol. Biol., 40, 255-261 (1991).
2. BULUN, S.E., NOBLE, L.S., TAKAYAMA, K., MICHEAL, M.D., AGARWAL, V., FISHER, C., ZHAO, Y., HINSHELWOOD, M.M., ITO, Y. and SIMPSON, E.R., Endocrine disorders associated with inappropriately high aromatase expression. J. Steroid Biochem. Mol. Biol., 61, 133-139 (1997).
3. EPPEN, C., SANTOS, E.J.M., MÄUELER, W., VAN HELDEN, P. and EPPLEN, J., On simple repetitive DNA sequences and complex diseases. Electrophoresis, 18, 1577-1585 (1997).
4. HAIMAN, C.A., HANKINSON, S.E., SPIEGELMAN, D., COLDITZ, G.A., WILLETT, W.C., SPEIZER, F.E., KELSEY, K.T. and HUNTER, D.J., The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res., 59, 1015-1020 (1999).
5. HANKINSON, S.E., MANSON, J.E., SPIEGELMAN, D., WILLETT, W.C., LONGCOPE, C. and SPEIZER, F.E., Reproducibility of plasma levels in postmenopausal women over 2-3 year period. Cancer Epidem. biol. Prev., 4, 649-654 (1995).
6. HANKINSON, S.E., WILLETT, W.C., MANSON, J.E., COLDITZ, G.A., HUNTER, D.J., SPIEGELMAN, D., BARBIERI, R.L. and SPEIZER, F.E., Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J. Nat. Cancer Inst., 90, 1292-1299 (1998).
7. HARADA, N., UTSUMI, T. and TAKAGI, Y., Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exon 1 in carcinogenesis. Mol. Endocrinol., 5, 2005-2013 (1993).
8. HEALEY, C.S., DUNNING, A.M., DUROCHER, F., TEARE, D., EASTON, D.F. and PONDER, B.A.J., Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk. Carcinogenesis (Lond.), in press (1999).
9. KRISTENSEN, V.N., ANDERSON, T.I., LINDBLOM, L., ERIKSTEIN, B., MAGNUS, P. and BÖRRENSEN-DALE, A.L., A rare CYP19 (aromatase) variant may increase the risk of breast cancer. Pharmacogenetics, 8, 43-48 (1998).
10. LIANG, K.Y. and ZEGER, S.L., Regression analysis for correlated data. Ann. Rev. Public Health, 14, 43-68 (1993).
11. arom gene: impact of estrogens on hypergonadotrophic hypogonadism, multicystic ovaries, and bone densitometry in children. J. clin. Endocrinol. Metab., 82, 1739-1745 (1997).
12. POLYMEROPOULOS, M.H., XIAO, H., RATH, D.S. and MERRIL, C.R., Tetranucleotide repeat polymorphism at the human aromatase cytochrome P-450 gene (CYP19). Nucleic Acids Res., 19, 195 (1991).
13. PROBST-HENSCH, N.M., INGLES, S.A., DIEP, A.T., HAILE, R.W., STANCZYK, F.Z., KOLONEL, L.N. and HENDERSON, B.E., Aromatase and breast cancer susceptibility. Endocrinol. Relat. Cancer, 6, 165-173 (1999).
14. SAS INSTITUTE, INC. SAS/STAT user's guide, version 6, edition 4. Cary, NC: SAS Institute, Inc. (1989).
15. SASANO, H., NAGURA, H., GOUKON, Y. and KIMURA, M. Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum. Pathol., 25, 530-535 (1994).
16. SHARMA, P., HINGORANI, A., JIA, H., ASHBY, M., HOPPER, R., CLAYTON, D. and BROWN, M.J., Positive association of tyrosine hydroxylase microsatellite marker to essential hypertension. Hypertension, 32, 676-682 (1998).
17. SIEGELMANN-DANIELI, N. and BUETOW, K.H., Constitutional genetic variation at the human aromatase gene (CYP19) and breast cancer risk. Br. J. Cancer, 79, 456-463 (1999).
18. SOURDAINE, P., PARKER, M.G., TELFORD, J. and MILLER, W.R., Analysis of the aromatase cytochrome P450 gene in human breast tumors. J. Mol. Endocrinol., 13, 331-337 (1994).
19. UTSUMI, T., HARADA, N., MARUTA, M. and TAKAGI, Y., Presence of alternatively spliced transcripts of aromatase gene in human breast cancer. J. clin. Endocrinol. Metab., 81, 2344-2349 (1996).
20. UWABO, J., SOMA, M., NAKAYAMA, T. and KANMATSUSE, K., Association of a variable number of tandem repeats in the endothelial constitutive nitric oxide synthase gene with essential hypertension in Japanese. Am. J. Hypertens., 11, 125-128 (1998).
21. WATANABE, J., HARADA, N., SUEMASU, K., HIGASHI, Y., GOTOH, O. and KAWAJIRI, K., Arginine-Cysteine polymorphism at codon 264 gene does not affect aromatase activity. Pharmacogenetics, 7, 419-424 (1997).
22. YUE, W., WANG, J.P., HAMILTON, C.J., DEMERS, L.M. and SANTEN, R.J., In situ aromatization enhances breast tumor estradiol levels and cellular proliferation. Cancer Res., 58, 927-932 (1998).